Home >> Life Sciences >> Pharmaceuticals

Beijing Tiantan Biological Products Co., Ltd. - Product Pipeline Review - 2015

Published: Oct-2015 | Format: PDF | Global Markets Direct | Number of pages: 21 | Code: MRS - 39479

Beijing Tiantan Biological Products Co., Ltd. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Beijing Tiantan Biological Products Co., Ltd. - Product Pipeline Review - 2015’, provides an overview of the Beijing Tiantan Biological Products Co., Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Beijing Tiantan Biological Products Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Beijing Tiantan Biological Products Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Beijing Tiantan Biological Products Co., Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Beijing Tiantan Biological Products Co., Ltd.’s pipeline products

Reasons to buy

- Evaluate Beijing Tiantan Biological Products Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Beijing Tiantan Biological Products Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Beijing Tiantan Biological Products Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Beijing Tiantan Biological Products Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Beijing Tiantan Biological Products Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Beijing Tiantan Biological Products Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Beijing Tiantan Biological Products Co., Ltd. Snapshot 5
Beijing Tiantan Biological Products Co., Ltd. Overview 5
Key Information 5
Key Facts 5
Beijing Tiantan Biological Products Co., Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Beijing Tiantan Biological Products Co., Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Combination Treatment Modalities 10
Beijing Tiantan Biological Products Co., Ltd. - Pipeline Products Glance 11
Beijing Tiantan Biological Products Co., Ltd. - Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
Beijing Tiantan Biological Products Co., Ltd. - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Beijing Tiantan Biological Products Co., Ltd. - Drug Profiles 13
meningococcal polysaccharide [serotypes A, C, Y, W-135] vaccine 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
poliomyelitis vaccine 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
measles + mumps + rubella + varicella vaccine 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
meningococcal [serotypes A and C] vaccine 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
pertussis vaccine 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Beijing Tiantan Biological Products Co., Ltd. - Pipeline Analysis 18
Beijing Tiantan Biological Products Co., Ltd. - Pipeline Products by Molecule Type 18
Beijing Tiantan Biological Products Co., Ltd. - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
Coverage 20
Secondary Research 20
Primary Research 20
Expert Panel Validation 20
Contact Us 20
Disclaimer 21

List of Tables
Beijing Tiantan Biological Products Co., Ltd., Key Information 5
Beijing Tiantan Biological Products Co., Ltd., Key Facts 5
Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Indication, 2015 7
Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Stage of Development, 2015 8
Beijing Tiantan Biological Products Co., Ltd. - Monotherapy Products in Pipeline, 2015 9
Beijing Tiantan Biological Products Co., Ltd. - Combination Treatment Modalities in Pipeline, 2015 10
Beijing Tiantan Biological Products Co., Ltd. - Phase I, 2015 11
Beijing Tiantan Biological Products Co., Ltd. - Preclinical, 2015 12
Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Molecule Type, 2015 18
Beijing Tiantan Biological Products Co., Ltd., Subsidiaries 19

List of Figures
Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Top 10 Indication, 2015 7
Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Stage of Development, 2015 8
Beijing Tiantan Biological Products Co., Ltd. - Monotherapy Products in Pipeline, 2015 9
Beijing Tiantan Biological Products Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015 18

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)1500 View Pricing